Search

everythinglearnresearchcommunity

for

Search:↓

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Hormones and genes affect hair growth and male baldness.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Alternative treatments show promise for hair growth beyond traditional methods.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Hirsutism causes significant psychological distress in women.

Chinese medicine may help hair growth and reduce hair loss in androgenetic alopecia.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Testosterone reduces key molecules needed for early pregnancy in rats.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

Most people in the surveyed area experience hair loss, but they are not aware of the role of diet, iron, hormones, genetics, and possibly water quality in causing it.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

The document concludes that skin and nail changes can indicate various underlying health conditions.